Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2003;34:776-782
Published online before print February 20, 2003, doi: 10.1161/01.STR.0000055763.76479.E6
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
34/3/776    most recent
01.STR.0000055763.76479.E6v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brault, S.
Right arrow Articles by Chemtob, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brault, S.
Right arrow Articles by Chemtob, S.
Related Collections
Right arrow Ischemic biology - basic studies
Right arrow Pathology of Stroke
Right arrow Endothelium/vascular type/nitric oxide

(Stroke. 2003;34:776.)
© 2003 American Heart Association, Inc.


Original Contributions

Selective Neuromicrovascular Endothelial Cell Death by 8-Iso-Prostaglandin F2{alpha}

Possible Role in Ischemic Brain Injury

Sonia Brault, MSc; Ana Katherine Martinez-Bermudez, MSc; Anne Marilise Marrache, BSc; Fernand Gobeil, Jr, PhD; Xin Hou, MD, PhD; Martin Beauchamp, BSc; Christiane Quiniou, MSc; Guillermina Almazan, PhD; Christian Lachance, MD; Jackson Roberts, II, MD, PhD; Daya R. Varma, MD, PhD Sylvain Chemtob, MD, PhD

From the Centre de Recherche de l’Hôpital Sainte-Justine, Department of Pediatrics and Pharmacology, Université de Montréal, Montréal, Québec, Canada (S.B., A.K.M-B., A.M.M., F.G., X.H., M.B., C.Q., C.L., S.C.); Department of Pharmacology and Therapeutics, McGill University, Montréal, Québec, Canada (S.B., A.K.M-B., A.M.M., G.A., D.R.V., S.C.); and Department of Pharmacology and Medicine, Vanderbilt University, Nashville, Tenn (J.R.).

Correspondence to Sylvain Chemtob, MD, PhD, FRCPC, Departments of Pediatrics, Ophthalmology, and Pharmacology, Research Center, Hôpital Sainte-Justine, 3175 Côte Sainte-Catherine, Montreal, Quebec H3T 1C5, Canada. E-mail sylvain.chemtob{at}umontreal.ca

Background and Purpose— Free radical-induced peroxidation is an important factor in the genesis of hypoxic-ischemic encephalopathy, including that of the preterm infant. Isoprostanes are major peroxidation products. Since microvascular dysfunction seems to contribute to ischemic encephalopathies, we studied the cytotoxicity of 8-iso-prostaglandin F2{alpha} (PGF2{alpha}) on cerebral microvascular cells.

Methods— Microvascular endothelial, astroglial, and smooth muscle cells from newborn brain were cultured. The cytotoxicity of 8-iso-PGF2{alpha} on these cells was determined by MTT assays and lactate dehydrogenase (LDH) release, propidium iodide incorporation, and DNA fragmentation (terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling [TUNEL]). In addition, effects of intraventricular injections of 8-iso-PGF2{alpha} and possible involvement of thromboxane in 8-iso-PGF2{alpha}-induced cytotoxicity were determined.

Results— 8-Iso-PGF2{alpha} induced time- and concentration-dependent endothelial cell death (EC50=0.1 nmol/L) but exerted little effect on smooth muscle and astroglial cells; endothelial cell death seemed mostly of oncotic nature (propidium iodide incorporation and LDH release). Cell death was associated with increased endothelial thromboxane A2 (TXA2) formation and was prevented by TXA2 synthase inhibitors (CGS12970 and U63557A); TXA2 mimetics U46619 and I-BOP also caused endothelial cell death. Intraventricular injection of 8-iso-PGF2{alpha} induced periventricular damage, which was attenuated by CGS12970 pretreatment.

Conclusions— These data disclose a novel action of 8-iso-PGF2{alpha} involving TXA2 in oxidant stress-induced cerebral microvascular injury and brain damage.


Key Words: apoptosis • brain damage • necrosis • oxidants • thromboxanes • white matter




This article has been cited by other articles:


Home page
Circ. Res.Home page
R. A. Benndorf, E. Schwedhelm, A. Gnann, R. Taheri, G. Kom, M. Didie, A. Steenpass, S. Ergun, and R. H. Boger
Isoprostanes Inhibit Vascular Endothelial Growth Factor-Induced Endothelial Cell Migration, Tube Formation, and Cardiac Vessel Sprouting In Vitro, As Well As Angiogenesis In Vivo via Activation of the Thromboxane A2 Receptor: A Potential Link Between Oxidative Stress and Impaired Angiogenesis
Circ. Res., October 24, 2008; 103(9): 1037 - 1046.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Quiniou, P. Sapieha, I. Lahaie, X. Hou, S. Brault, M. Beauchamp, M. Leduc, L. Rihakova, J.-S. Joyal, S. Nadeau, et al.
Development of a Novel Noncompetitive Antagonist of IL-1 Receptor
J. Immunol., May 15, 2008; 180(10): 6977 - 6987.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. Brault, F. Gobeil Jr., A. Fortier, J.-C. Honore, J.-S. Joyal, P. S. Sapieha, A. Kooli, E. Martin, P. Hardy, A. Ribeiro-da-Silva, et al.
Lysophosphatidic acid induces endothelial cell death by modulating the redox environment
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2007; 292(3): R1174 - R1183.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
G. Cambonie, B. Comte, C. Yzydorczyk, T. Ntimbane, N. Germain, N. L. O. Le, P. Pladys, C. Gauthier, I. Lahaie, D. Abran, et al.
Antenatal antioxidant prevents adult hypertension, vascular dysfunction, and microvascular rarefaction associated with in utero exposure to a low-protein diet
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2007; 292(3): R1236 - R1245.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
P. Wentzel and U. J. Eriksson
Ethanol-Induced Fetal Dysmorphogenesis in the Mouse Is Diminished by High Antioxidative Capacity of the Mother
Toxicol. Sci., August 1, 2006; 92(2): 416 - 422.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
C. Quiniou, F. Sennlaub, M. H. Beauchamp, D. Checchin, I. Lahaie, S. Brault, F. Gobeil Jr., M. Sirinyan, A. Kooli, P. Hardy, et al.
Dominant Role for Calpain in Thromboxane-Induced Neuromicrovascular Endothelial Cytotoxicity
J. Pharmacol. Exp. Ther., February 1, 2006; 316(2): 618 - 627.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
P. Pladys, F. Sennlaub, S. Brault, D. Checchin, I. Lahaie, N. L. O. Le, K. Bibeau, G. Cambonie, D. Abran, M. Brochu, et al.
Microvascular rarefaction and decreased angiogenesis in rats with fetal programming of hypertension associated with exposure to a low-protein diet in utero
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2005; 289(6): R1580 - R1588.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. J. Gonzales, A. A. Ghaffari, S. P. Duckles, and D. N. Krause
Testosterone treatment increases thromboxane function in rat cerebral arteries
Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H578 - H585.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
J.-L. Cracowski and O. Ormezzano
Isoprostanes, emerging biomarkers and potential mediators in cardiovascular diseases
Eur. Heart J., October 1, 2004; 25(19): 1675 - 1678.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H. Shibata, T. Nabika, H. Moriyama, J. Masuda, and S. Kobayashi
Correlation of NO Metabolites and 8-Iso-Prostaglandin F2a With Periventricular Hyperintensity Severity
Arterioscler Thromb Vasc Biol, September 1, 2004; 24(9): 1659 - 1663.
[Abstract] [Full Text] [PDF]